• Black, A.J., McLeod, H.L., Capell, H.A., Powrie, R.H., Matowe, L.K., Pritchard, S.C., Collie-Duguid, E.S.R., Reid, D.M. (1998) Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azothioprine. Annals of Internal Medicine, 129, 716718.
  • Coultard, S.A., Rabello, C., Robson, J., Howell, C., Minto, L., Middleton, P.G., Gandhi, M.K., Jackson, G., McLelland, J., O'Brien, H., Smith, S., Reid, M.M., Pearson, A.D.J., Hall, A.G. (2000) A comparison of molecular and enzyme-based assays for the detection of thiopurine methyltransferase mutations. British Journal of Haematology, 110, 599604.DOI: 10.1046/j.1365-2141.2000.02218.x
  • Relling, M.V., Hancock, M.L., Rivera, G.K., Sandlund, J.T., Ribeiro, R.C., Krynetski, E.Y., Pui, C.H., Evans, W.E. (1999) Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. Journal of the National Cancer Institute, 91, 20012008.DOI: 10.1093/jnci/91.23.2001
  • Yates, C.R., Krynetski, E.Y., Loennechen, T., Fessing, M.Y., Tai, H.L., Pui, C.H., Relling, M.V., Evans, W.E. (1997) Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Annals of Internal Medicine, 126, 608614.